Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Blood Advances Année : 2023

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group

Yassine Al Tabaa
  • Fonction : Auteur
Jean Marc Schiano de Colella
Guillaume Cartron

Domaines

Cancer

Dates et versions

hal-04239554 , version 1 (12-10-2023)

Identifiants

Citer

Yassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, Emmanuel Bachy, Emmanuelle Nicolas-Virelizier, et al.. Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group. Blood Advances, 2023, 7 (14), pp.3735-3738. ⟨10.1182/bloodadvances.2023009911⟩. ⟨hal-04239554⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More